"Designing Growth Strategies is in our DNA"
The global pressure ulcer treatment market size stood at USD 6.69 billion in 2018 and is projected to reach USD 11.23 billion by 2026, exhibiting a CAGR of 6.7% during the forecast period.
Pressure ulcers, also termed as bedsores or decubitus ulcers are injuries to the skin and the underlying tissue resulting from prolonged pressure on the skin. They commonly occur on the skin of bony areas of the body such as elbow, buttocks, heels, ankles, back, and shoulder. Pressure ulcers mostly affect those who are immobilized due to illness, injury or sedation, or those who spend most of their time on bed or on a chair. They occur in 4 stages. Identifying them in early stages enables the treatment and reduces the risk of complications such as cellulitis, bone and joint infections, sepsis, or cancer.
Request a Free sample to learn more about this report.
The market is likely to be propelled by factors, such as a substantial rise in the geriatric population living with disabilities, a rapidly increasing prevalence of pressure ulcers, and the growing adoption of novel wound care devices for its treatment. According to the Agency for Healthcare Research & Quality (AHRQ), more than 2.5 million individuals in the U.S. develop pressure ulcers annually. The increasing awareness about the availability of treatment options for PU, the rise in healthcare expenditures, and an increase in advanced treatment procedures are anticipated to propel the pressure ulcer treatment market growth during the forecast period. Combined with this, a rise in the demand for multiple treatment options by patients diagnosed around the globe is likely to increase the pressure ulcer market size during the forecast period.
“Increasing Prevalence of Pressure Ulcer Globally to Accelerate Growth of Market”
Pressure ulcer is one of the costliest and physically debilitating complications in the 20th century. Various factors such as advancing age, sedentary lifestyle, mobility problems, and various health conditions have been responsible for increasing the prevalence of pressure ulcers. According to an article published by NCBI, a prevalence of 12.7% in Brazil, 10.4% in Turkey, and 16% in Ethiopia were reported for pressure ulcers in 2018. These trends are presenting a large patient pool seeking treatment. This, along with the increasing awareness among the patient population about the availability of treatment and rise in healthcare expenditure, especially in the emerging countries are anticipated to further augment the global market growth during the forecast period.
“Substantial Rise in Geriatric Population to Augment the Market Growth”
The elderly are more susceptible to the development of the skin lesions as a result of changes associated with the aging process. Prolonged life expectancy has increased the number of people aged over 80 years, thus being placed at a higher risk of immobility and disability. According to the National Institute of Health (NIH), in 2016, about 8.5% of people worldwide (615 million) were aged 65 and over. Also, according to a research article published by HMP Wound Care, 71% of pressure ulcers occur in patients older than 70 years. Hence, an increasing geriatric population is expected to augment the market growth during the forecast period.
“Stage 4 Segment Expected to Dominate the Pressure Ulcer Treatment Market”
Based on ulcer type, the market is segmented into stage 1, stage 2, stage 3, and stage 4. Among them, the stage 4 segment is expected to dominate the market during the forecast period owing to the higher treatment costs as compared to the other stages. For instance, according to a study by the National Institute for Health And Care Excellence (NICE), the treatment expenses for stage 4 ulcer and stage 1 ulcer are $16,617.4 and $1,429.8, respectively.
On the other hand, the stage 2 ulcer segment is anticipated to exhibit the highest CAGR due to their increasing prevalence and subsequent rising adoption of treatment options for this type of pressure ulcer.
To know how our report can help streamline your business, Speak to Analyst
“Wound Care Dressings Segment to Hold a Leading Market Share”
Among product type, the wound care dressing segment is expected to dominate and continue to expand at a considerably high growth rate during the forecast period. This is due to their higher adoption as they are the primary treatment option and also speed up the healing process of pressure ulcer. Increasing investments by key market players in new launches of this segment, comparatively lower cost of care, and rising awareness among the patients regarding wound care dressings are some of the other major factors that are expected to propel the growth of this segment during the forecast period. For instance, in February 2019, AxioBiosolutions launched MaxioCel, a next-generation wound care dressing made of chitosan for the treatment of pressure ulcers.
“Hospitals Segment to Continue Its Dominance till 2026 in the Global Market”
On the basis of end-user, the market can be segmented into hospitals, clinics, ambulatory surgical centers, and home care settings. The hospital segment is expected to have a dominant pressure ulcer treatment market share during the forecast period owing to a higher adoption rate of treatment options for pressure ulcers in hospitals, the presence of required facility skilled staff, and increasing patient preference for hospitals due to favorable policies.
The home care setting segment is expected to exhibit the fastest growth owing to a rise in the geriatric patient population and shift in preference from a hospital visit to self-care at home care settings for the treatment of pressure ulcers. The clinics segment is likely to expand considerably owing to the increase in the number of specialty clinics with advanced facilities, trained staff, and personalized wound care.
Geographically, the global industry is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among them, North America accounted for the largest share in the market in the year 2018. This is attributable to the increasing prevalence of pressure ulcers, improved healthcare facilities, increasing new launches of advanced technologies, and the high cost of products in this region.
North America Pressure Ulcer Treatment Market Size, 2018
To get more information on the regional analysis of this market, Request a Free sample
Europe accounted for the second-largest share in the pressure ulcer treatment market. The rising geriatric population and increasing prevalence of pressure ulcers are anticipated to drive the market in this region. Combined with this, higher treatment costs of pressure ulcers in countries such as Germany, France, and the U.K. are expected to create growth opportunities for the market in the forthcoming years. For instance, in the U.K., the cost of treatment of pressure ulcers to the NHS is estimated to be USD 1.5 – USD 2.4 billion annually, making pressure ulcers the single costliest chronic wound to the NHS.
On the other hand, Asia Pacific is projected to register a higher CAGR during the forecast period due to the rapidly increasing geriatric population, along with the growing patient pool of pressure ulcers in the region. For instance, the United Nations Population Fund (UNFPA), currently stated that the geriatric population in Asia Pacific is rising at an unprecedented rate. It also states that by 2050, one in four people in this region will be above 60 years of age. Latin America and the Middle East & Africa are anticipated to witness lucrative growth during the forecast period owing to the rising awareness regarding the availability of treatment options for pressure ulcers and developing health care facilities.
“Mölnlycke Health Care AB, B. Braun Melsungen AG, and ConvaTec Group Plc Dominate the Market”
Mölnlycke Health Care AB, B. Braun Melsungen AG, and ConvaTec Group Plc. are the leading players in the pressure ulcer treatment market. The major reason for their dominance is their strong brand presence, combined with a wide range of product offerings. These players are likely to continue their dominance and generate significant PU treatment market revenue in the upcoming years owing to the robust research activities and increasing investments in innovative product launches. For instance, in May 2018, B. Braun Melsungen AG launched a patient-friendly 1-ounce tube of Prontosan Wound Gel X at the 2018 Symposium of Advanced Wound Care, North Carolina for the treatment of pressure ulcers and diabetic foot ulcers.
Other players involved in pressure ulcer treatment with a considerable market share include Smith & Nephew, 3M, Integra LifeSciences Corporation, Cardinal Health, Tissue Regenix, and others.
An Infographic Representation of Pressure Ulcer Treatment Market
To get information on various segments, share your queries with us
The pressure ulcer treatment market report provides detailed information regarding various insights into the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2019 to 2026 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources.
Value (USD Billion)
By Ulcer Type
By Product Type
By End User
Based on the detailed study conducted by Fortune Business Insights, the global market size was USD 6.69 billion in 2018.
According to Fortune Business Insights, the global pressure ulcer treatment market will reach USD 11.23 billion by 2026.
The pressure ulcer treatment market is projected to grow at a CAGR of 6.7% during the forecast period (2019-2026).
North America is expected to hold the highest share in the market.
The rising prevalence of pressure ulcer among the global population and the introduction of technologically advanced treatment options by market players are the key factors driving the market.
Molnlycke Health Care AB, B. Braun Melsungen AG, and ConvaTec Group Plc. are the top companies in the market.
Wound care dressing is the leading segment in the pressure ulcer treatment market by product.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry